PCR51 Reassessing the Acceptability of Risk of Death Associated With Gene Therapy for Duchenne Muscular Dystrophy: A Qualitative Study to Inform Updating a Quantitative Instrument
Abstract
Authors
H Peay E Heslop R Fischer H Cope M McNiff